162 related articles for article (PubMed ID: 2212945)
1. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.
Celada F; Cambiaggi C; Maccari J; Burastero S; Gregory T; Patzer E; Porter J; McDanal C; Matthews T
J Exp Med; 1990 Oct; 172(4):1143-50. PubMed ID: 2212945
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.
DeVico AL; Rahman R; Welch J; Crowley R; Lusso P; Sarngadharan MG; Pal R
Virology; 1995 Aug; 211(2):583-8. PubMed ID: 7544051
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
Burkly L; Mulrey N; Blumenthal R; Dimitrov DS
J Virol; 1995 Jul; 69(7):4267-73. PubMed ID: 7769687
[TBL] [Abstract][Full Text] [Related]
4. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
Callahan LN; Phelan M; Mallinson M; Norcross MA
J Virol; 1991 Mar; 65(3):1543-50. PubMed ID: 1995952
[TBL] [Abstract][Full Text] [Related]
5. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.
Healey D; Dianda L; Moore JP; McDougal JS; Moore MJ; Estess P; Buck D; Kwong PD; Beverley PC; Sattentau QJ
J Exp Med; 1990 Oct; 172(4):1233-42. PubMed ID: 1698911
[TBL] [Abstract][Full Text] [Related]
6. Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.
Cordell J; Moore JP; Dean CJ; Klasse PJ; Weiss RA; McKeating JA
Virology; 1991 Nov; 185(1):72-9. PubMed ID: 1718090
[TBL] [Abstract][Full Text] [Related]
7. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.
Pantophlet R; Ollmann Saphire E; Poignard P; Parren PW; Wilson IA; Burton DR
J Virol; 2003 Jan; 77(1):642-58. PubMed ID: 12477867
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 rgp120 binding to CD4+ T cells by monoclonal antibodies directed against the gp120 C1 or C4 region.
Kröpelin M; Süsal C; Daniel V; Opelz G
Immunol Lett; 1998 Aug; 63(1):19-25. PubMed ID: 9719434
[TBL] [Abstract][Full Text] [Related]
9. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
[TBL] [Abstract][Full Text] [Related]
10. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278
[TBL] [Abstract][Full Text] [Related]
11. Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct.
Lederman S; Bergmann JE; Cleary AM; Yellin MJ; Fusco PJ; Chess L
AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1599-610. PubMed ID: 1457206
[TBL] [Abstract][Full Text] [Related]
12. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice.
Boudet F; Theze J; Zouali M
Virology; 1994 Apr; 200(1):176-88. PubMed ID: 7510435
[TBL] [Abstract][Full Text] [Related]
13. Production of a human anti-CD4 monoclonal antibody with antiidiotype to anti-HIV type 1 glycoprotein 120.
Karpatkin S; Nardi MA; Liu LX; Kouri YH; Borkowsky W
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):509-15. PubMed ID: 7632465
[TBL] [Abstract][Full Text] [Related]
14. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
Ho DD; Fung MS; Cao YZ; Li XL; Sun C; Chang TW; Sun NC
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8949-52. PubMed ID: 1717992
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of HIV-1 by anti-idiotypes to monoclonal anti-CD4. Potential for idiotype immunization against HIV.
Sutor GC; Dreikhausen U; Vähning U; Jurkiewicz E; Hunsmann G; Lundin K; Schedel I
J Immunol; 1992 Aug; 149(4):1452-61. PubMed ID: 1500724
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.
Lee S; Peden K; Dimitrov DS; Broder CC; Manischewitz J; Denisova G; Gershoni JM; Golding H
J Virol; 1997 Aug; 71(8):6037-43. PubMed ID: 9223495
[TBL] [Abstract][Full Text] [Related]
18. Mouse monoclonal antibodies to human immunodeficiency virus glycoprotein 120 generated by repeated immunization with glycoprotein 120 from a single isolate, or by sequential immunization with glycoprotein 120 from three isolates.
Reeves JP; Lo CY; Klinman DM; Epstein SL
Hybridoma; 1995 Jun; 14(3):235-42. PubMed ID: 7590785
[TBL] [Abstract][Full Text] [Related]
19. Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity.
Ashkenazi A; Smith DH; Marsters SA; Riddle L; Gregory TJ; Ho DD; Capon DJ
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7056-60. PubMed ID: 1871120
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
